Effects of Social Networking on Chronic Disease Management in Arthritis

NCT ID: NCT02717403

Last Updated: 2023-06-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

210 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-04-07

Study Completion Date

2023-06-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objectives:

The overall goal of this study is to use the principles of chronic disease management to develop and test an online social networking intervention using the FB platform in a randomized controlled trial. Our specific objectives are as follows:

Aim 1: To develop and establish an independent closed community in FB for patients with rheumatoid arthritis, providing an educational platform for disease self-management and the potential for engaging in social networking with peers (Phase 2).

Objective 1. To beta test the features and navigation buttons and panels in the newly developed website and FB group.

Objective 2. To evaluate the contents, ease of use and satisfaction with the newly developed website and FB group by patient advocates (consultants to the study) who participate as members of the Facebook community.

Aim 2: To evaluate the efficacy of the FB community intervention combined with an educational website to improve patients' self-management (including knowledge, which is the primary outcome), decision making and patient-reported outcomes compared with the educational website alone (Phase 3). We hypothesize that participation in an online closed community offering evidence-based information combined with peer interaction and support will improve patients' knowledge.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pilot Testing Phase:

Five participants will be recruited to pilot test and give feedback on the control educational website and the FB community. Participants will have access to the educational website and FB, for a period of one week. The main purpose is to test ease of use and satisfaction with both platforms. After 1 week, research staff will call the participant to obtain feedback about the websites. The interview will last approximately 30 minutes and in the case the participant does not finish the interview, the investigators will conduct a follow-up phone interview.

Randomization Phase:

Participants will complete a self response electronic questionnaire at baseline. Participants then randomized into one of two arms: Intervention (FB + Website) and Control (Website alone). The participant will be shown how to access the website and the Facebook page on the internet about rheumatoid arthritis. Patients will be assessed at three and six months after baseline via email self response electronic questionnaires. This phase will recruit 220 participants.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Disease Management Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Facebook + Website Group

Participants complete a self response electronic questionnaire at baseline. Participant shown how to access the Educational Website and the Facebook page on the internet about rheumatoid arthritis. Patients assessed at three and six months after baseline via email self response electronic questionnaires.

Group Type EXPERIMENTAL

Questionnaires

Intervention Type BEHAVIORAL

Participants complete a self response electronic questionnaire at baseline, and at three and six months.

Facebook

Intervention Type BEHAVIORAL

Participant accesses Facebook page regarding rheumatoid arthritis.

Educational Website

Intervention Type BEHAVIORAL

Participant accesses Educational Website on the internet about rheumatoid arthritis.

Educational Website Group

Participants complete a self response electronic questionnaire at baseline. Participant shown how to access the Educational Website on the internet about rheumatoid arthritis. Content includes the following: (i) a learning center; (ii) relevant links to other evidence-based web pages; (iii) news released by major rheumatology and dermatology organizations/societies; and (iv) chronic disease management strategies. Participants assessed at three and six months after baseline via email self response electronic questionnaires.

Group Type EXPERIMENTAL

Questionnaires

Intervention Type BEHAVIORAL

Participants complete a self response electronic questionnaire at baseline, and at three and six months.

Educational Website

Intervention Type BEHAVIORAL

Participant accesses Educational Website on the internet about rheumatoid arthritis.

Pilot Testing Group

Participants access the Educational Website and Facebook page about rheumatoid arthritis for a period of one week. After 1 week, research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.

Group Type EXPERIMENTAL

Facebook

Intervention Type BEHAVIORAL

Participant accesses Facebook page regarding rheumatoid arthritis.

Educational Website

Intervention Type BEHAVIORAL

Participant accesses Educational Website on the internet about rheumatoid arthritis.

Phone Interview

Intervention Type BEHAVIORAL

Research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Participants complete a self response electronic questionnaire at baseline, and at three and six months.

Intervention Type BEHAVIORAL

Facebook

Participant accesses Facebook page regarding rheumatoid arthritis.

Intervention Type BEHAVIORAL

Educational Website

Participant accesses Educational Website on the internet about rheumatoid arthritis.

Intervention Type BEHAVIORAL

Phone Interview

Research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Surveys Social Media

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18 years or older (usability test and RCT)
2. Staff of the Department of General Internal Medicine (usability test)
3. Diagnosis of rheumatoid arthritis by a rheumatologist (RCT)
4. Ongoing or prior treatment with traditional disease-modifying anti-rheumatic drugs or biologic agents (RCT)
5. Adequate cognitive status as determined by a research coordinator at recruitment. To assess the participant's capacity to take part in the interview, the interviewer will note and comment on the participant's spontaneous speech and capacity to write date at the time of consent. Participants should be oriented to person, place, date, time, and events (RCT)
6. Living in the community (not institutionalized, etc. ) (RCT)
7. Able to communicate in English (RCT)
8. Use internet on average at-least once a week (RCT);
9. Disease duration 10 years or less (RCT)
10. Familiarity with and participation in social media (e.g. Facebook) (usability test and RCT)

Exclusion Criteria

1. Participants not willing to complete interviews or survey instruments (usability test and RCT)
2. Hospitalized (RCT)
3. Patients who do not verbally, written, or electronically consent to participate (usability test and RCT)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rheumatology Research Foundation

OTHER

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Angeles M. Lopez-Olivo, MD, PHD, MS

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Lopez-Olivo MA, Foreman JT, Leung C, Lin HY, Westrich-Robertson T, Hofstetter C, des Bordes JKA, Lyddiatt A, Leong A, Willcockson IU, Peterson SK, Suarez-Almazor ME. A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum. 2022 Oct;56:152072. doi: 10.1016/j.semarthrit.2022.152072. Epub 2022 Jul 16.

Reference Type DERIVED
PMID: 35872394 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

University of Texas MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

14038089

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

NCI-2016-00563

Identifier Type: REGISTRY

Identifier Source: secondary_id

2015-0349

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.